Disputes for Breakfast: Riidanratkaisijan näkökulmia patentin suojapiirin laajuuteen

D&I Webinar

Event date

10 Sep

2024

Dittmar & Indrenius > Insight > Disputes for Breakfast: Riidanratkaisijan näkökulmia patentin suojapiirin laajuuteen

Webinaari torstaina 10.9.2024 klo 8.30 – 9.30

D&I Dispute Powerhousen Disputes for Breakfast -webinaarisarjan toisessa osassa kesäkuussa Juli Mansnérus ja Johanna Ahola puhuvat patentin suojapiiriin laajuuteen liittyvistä kysymyksistä ja tarjoavat riidanratkaisijan näkökulmia aihepiiriin.

Webinaarissa tarkastellaan muun muassa seuraavia kysymyksiä:

  • Mikä merkitys on patentin suojapiirin laajuudella?
  • Mitkä tekijät vaikuttavat patentin suojapiirin laajuuteen ja kuinka patenttiriitoja voisi ennaltaehkäistä?
  • Miltä näyttävät tulevaisuuden kehityssuunnat?

Jos et ole saanut kutsua ja haluaisit osallistua webinaareihin, voit olla yhteydessä: thinkingahead@dittmar.fi.

More by the same author

The EU’s Pharmaceutical Legislation Reform

The European Union’s imminent pharmaceutical legislation reform aims to modernise its regulatory framework, focusing on improving patient access to medicines, fostering innovation, and minimising environmental impact. This strategic overhaul, set against a backdrop of industry challenges and evolving IP rights, underscores the EU’s commitment to balancing innovation with accessibility and sustainability in healthcare.

The European Parliament and the Council reach an agreement on European Health Data Space!

Towards a stronger European Health Union On March 15, 2024, the European Parliament and the Belgian Presidency of the Council reached a provisional political agreement on the European Health Data Space (EHDS) which is considered one of the central building blocks towards a stronger European Health Union. The upcoming EHDS aims to harness the full potential offered by the sharing, use, and re-use of health data, while ensuring full compliance with the data protection standards in the EU. This marks a significant milestone in the EU’s health data regulation.

Commission proposes extension of IVDR transition periods for legacy products

The European Commission has on 23 January 2024 announced a proposal for an extension to the transition period for the forthcoming In Vitro Diagnostic Medical Devices Regulation (IVDR). The aim is to ensure patient care by improving the availability of these essential healthcare products. In addition, the Commission also proposes measures to enable and accelerate a gradual roll out of EUDAMED, a database that will contain information about all medical devices and in vitro diagnostics (IVDs) placed on the EU market. The mandatory use of finalised parts of EUDAMED will support all key players in the implementation of the regulatory framework and enhance transparency for the public.

Latest insights

Draft New Act Governing Offshore Wind Power within the Finnish EEZ Published for Comments

Alert / 28 May 2024
Reading time 2 minutes

Government proposal regarding the implementation of EU’s NIS 2 Directive published

Alert / 24 May 2024
Reading time 2 minutes